Search

everythinglearnresearchcommunity

for

Search:↓

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

A woman with Sheehan syndrome improved with hormone treatment.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

A boy's hair loss improved after tumor removal and vitamin D treatment, but hair loss returned despite normal vitamin D and no tumor regrowth.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

A six-year-old girl has early signs of puberty, needs no treatment, but requires regular check-ups for future health risks.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Alopecia areata patients often have autoimmune disorders, especially thyroid issues.

Mothers with atopic dermatitis have higher risks of pregnancy complications and their children are more likely to develop certain health conditions.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Endocrine diseases in children often cause skin changes like dryness, redness, acne, hair loss, and more.

A woman with severe hypothyroidism had a rare skin condition usually linked to a different thyroid disease.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Two siblings both had a rare case of alopecia areata at the same time.